RARRES2 and obesity disorder: Chemerin was evidenced as a valuable biomarker for diagnosis in a wide range of diseases, including obesity [145], cardiovascular diseases [146], T2DM [146], male subfertility [45], PCOS [86], and cytomegalovirus-induced intrauterine infection [147].